Cipla Limited (NSE: CIPLA, BSE: 500087), a leading global pharmaceutical company, has announced that it has secured final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial. This approval was granted on April 10, 2025.
Cipla’s Protein-bound Paclitaxel is an AB-rated generic therapeutic equivalent of Bristol Myers Squibb’s Abraxane®, a widely used injectable suspension. The drug is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer (NSCLC), and metastatic adenocarcinoma of the pancreas.
Advertisement
The company has announced plans to launch this product in the U.S. market during the first half of FY2025-26. This strategic move aligns with Cipla’s commitment to expanding its oncology portfolio and providing cost-effective treatment options to patients worldwide.
Rajendra Chopra, Company Secretary of Cipla Limited, confirmed these developments in a regulatory filing with stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
Also read: UCO Bank’s Zonal Head for Guwahati is now Satya Ranjan Panda.
Published on: April 10, 2025 / M Vishnu
Pink Moon spotted across India
The full moon early this morning was popularly known as the ‘Pink Moon’. Though not actually pink, it marks the spring season and was visible clearly around 5:00 AM in many parts of India.
As stated in Bhagavad Gita:
यः करोत्यः संकल्पः संकल्पः संकल्पः।
The one who is unattached to the external world and who is free from desires is truly a yogi.
